Explore 3 Stock Ideas & Industry Insights Download Free Report

Company price
None USD 0.00(0%)
Last update at 2026-11-03T21:04:47.093181Z
Market Cap
870.57M

Momentum Score

…

Talkspace, Inc., together with its subsidiaries, operates as a virtual behavioral healthcare company that connects patients with licensed mental health providers in the United States. The company provides psychotherapy and psychiatry services to treat various mental health conditions, such as depression, anxiety, trauma, and other fields of human challenges by operating an online platform for one-on-one therapy delivered through messaging, audio, and video channels. It serves health insurance plans and employee assistance programs, direct-to-enterprise customers, and individual subscribers. The company was formerly known as Groop Internet Platform Inc. and changed its name to Talkspace, Inc. in June 2021. The company was founded in 2012 and is headquartered in New York, New York. As of August 17, 2026, Talkspace, Inc. operates as a subsidiary of Universal Health Services, Inc.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
2.56
Low
16.50
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Talkspace operates a digital mental-health platform connecting users with licensed therapists via messaging and video for consumers and employer/payer clients. Long-term growth may be driven by rising demand for mental-health services, telehealth adoption and expansion of employer and payer contracts, which could support scalable recurring revenue.
Key risks include intense competition, challenges achieving sustained profitability and scale, reimbursement and regulatory uncertainty, clinician supply constraints and data-privacy obligations.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
13.10
Dividend Yield
-
Revenue TTM
245.73M
Revenue Per Share
1.47
Gross Profit TTM
94.80M
Debt / Equity
-
ROE
0.17%
Net Debt
-37.35M
ROCE
7.12%
Diluted EPS TTM
-0.01

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 8.37M 1.24M -18.96M -79.42M -62.70M
Net income 7.79M 1.15M -19.18M -79.67M -62.74M
Selling general administrative 21.77M 22.63M 21.32M 36.27M 34.77M
Selling and marketing expenses 53.80M 50.65M 52.54M 72.84M 100.64M
Gross profit 98.35M 85.84M 74.38M 60.34M 66.77M
Reconciled depreciation 2.88M 0.86M 1.26M 1.36M 1.97M
Ebit 8.37M 1.24M -18.96M -77.02M -93.92M
Ebitda 11.24M 2.10M -17.77M -69.53M -91.95M
Depreciation and amortization 2.88M 0.86M 1.20M 7.49M 1.97M
Operating income 3.15M -4.50M -23.21M -77.02M -93.92M
Other operating expenses 225.72M 192.09M 173.25M 196.59M 207.59M
Interest expense - - - 3.74M 31.23M
Tax provision 0.57M 0.09M 0.29M 0.25M 0.05M
Interest income - - - 3.74M -
Net interest income 5.21M 5.74M 5.77M 3.74M 31.23M
Income tax expense 0.57M 0.09M 0.22M 0.25M 0.05M
Total revenue 228.87M 187.59M 150.04M 119.57M 113.67M
Total operating expenses 95.20M 90.33M 97.59M 137.36M 160.69M
Cost of revenue 130.52M 101.76M 75.67M 59.23M 46.90M
Total other income expense net 5.21M 5.74M 4.25M -2.39M 31.23M
Net income from continuing ops 7.79M 1.15M -36.18M -79.67M -62.74M
Net income applicable to common shares - - - -79.67M -62.74M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 134.86M 138.68M 142.22M 156.25M 223.61M
Intangible assets 3.87M 1.34M 1.79M 2.53M 3.44M
Other current assets 2.42M 2.73M 5.72M 4.37M 9.56M
Total liab 17.85M 21.28M 23.57M 28.72M 31.33M
Total stockholder equity 117.02M 117.39M 118.65M 127.54M 192.27M
Other current liab 6.67M 8.03M 12.47M 16.50M 2.59M
Common stock 0.02M 0.02M 0.02M 0.02M 0.01M
Capital stock 0.02M 0.02M 0.02M 0.02M 0.01M
Retained earnings -261.44M -269.24M -270.38M -251.20M -171.53M
Other liab - - - 1.20M 4.16M
Good will 3.32M 0.00M - 0.00M 6.13M
Other assets - - 0.00M 0.09M 0.08M
Cash 37.35M 76.69M 123.91M 138.54M 198.26M
Total current liabilities 17.40M 19.02M 21.65M 27.32M 27.18M
Current deferred revenue 2.22M 3.28M 3.07M 4.36M 7.19M
Net debt -37.35M -76.69M -123.91M -138.54M -198.26M
Short term debt - - - - 9.97M
Other stockholder equity 378.38M 386.61M 389.01M 378.72M 363.79M
Property plant equipment - - - 0.68M 0.62M
Total current assets 111.06M 130.18M 139.80M 152.56M 213.33M
Net tangible assets - - - 125.01M 182.70M
Short term investments 55.23M 41.12M - - -
Net receivables 16.06M 9.64M 10.17M 9.64M 5.51M
Accounts payable 8.50M 7.71M 6.11M 6.46M 7.43M
Accumulated other comprehensive income 0.06M 0.00M - - -223.61M
Common stock total equity - - - 0.02M 0.01M
Retained earnings total equity - - - -251.20M -171.53M
Non currrent assets other 0.82M 0.90M 0.32M 0.49M 0.08M
Non current assets total 23.80M 8.49M 2.42M 3.70M 10.28M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments -13.26M -46.73M -0.07M -0.32M -0.66M
Change to liabilities - - - 4.00M 2.52M
Total cashflows from investing activities -28.88M -46.31M -0.14M -0.32M -0.66M
Net borrowings - - 0.00M - -
Total cash from financing activities -19.00M -12.19M 1.90M 1.68M 251.38M
Change to operating activities - - - 10.04M -3.66M
Net income -5.21M 1.15M -19.18M -79.67M -62.74M
Change in cash -39.34M -47.22M -14.64M -59.71M 185.01M
Begin period cash flow 76.69M 123.91M 138.54M 198.26M 13.25M
End period cash flow 37.35M 76.69M 123.91M 138.54M 198.26M
Total cash from operating activities 8.53M 11.29M -16.39M -61.08M -65.71M
Issuance of capital stock - - - - 0.00M
Depreciation 2.88M 0.86M 1.20M 1.36M 1.97M
Other cashflows from investing activities -0.07M -0.17M 0.01M 0.03M -
Change to inventory - - - - -3.66M
Change to account receivables -6.42M 0.53M -0.53M -4.13M 0.40M
Sale purchase of stock -17.20M -11.00M 0.00M 3.18M 2.05M
Other cashflows from financing activities -2.71M -3.19M -0.81M -1.50M 257.38M
Change to netincome - - - 18.25M -4.38M
Capital expenditures 10.64M 5.44M 0.15M 0.35M 0.66M
Change receivables - - - -4.13M 0.40M
Cash flows other operating - - - -0.88M -37.82M
Cash and cash equivalents changes - - - -59.71M 185.01M
Change in working capital -8.23M 0.90M -7.55M 2.12M -0.74M
Stock based compensation 8.45M 9.17M 8.39M 12.12M 27.41M
Other non cash items 10.66M -0.79M 0.75M 3.00M 0.17M
Free cash flow -2.11M 5.84M -16.54M -61.43M -66.37M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
VEEV
Veeva Systems Inc Class A
-3.11
1.01%
303.89 43.49 29.59 12.48 5.79 10.39 33.41
PMCUF
Pro Medicus Limited
-
-%
132.14 64.90 90.91 49.11 38.05 65.12 83.47
TEM
Tempus AI, Inc. Class A Common Stock
-0.75
0.96%
77.73 - - 8.68 25.39 8.33 -
MTHRY
M3 Inc
-0.05
0.87%
5.70 31.84 26.25 0.05 4.60 0.04 0.12

Profile*

Talkspace Inc

Talkspace, Inc., together with its subsidiaries, operates as a virtual behavioral healthcare company that connects patients with licensed mental health providers in the United States. The company provides psychotherapy and psychiatry services to treat various mental health conditions, such as depression, anxiety, trauma, and other fields of human challenges by operating an online platform for one-on-one therapy delivered through messaging, audio, and video channels. It serves health insurance plans and employee assistance programs, direct-to-enterprise customers, and individual subscribers. The company was formerly known as Groop Internet Platform Inc. and changed its name to Talkspace, Inc. in June 2021. The company was founded in 2012 and is headquartered in New York, New York. As of August 17, 2026, Talkspace, Inc. operates as a subsidiary of Universal Health Services, Inc.

622 Third Avenue, New York, NY, United States, 10017

212 284 7206

598

Name Title Year Born
Ms. Jennifer Fulk Chief Financial Officer 1977
Mr. Gil Margolin Chief Technology Officer 1978
Mr. John Charles Reilly Gen. Counsel & Corp. Sec. 1966
Dr. Jon R. Cohen M.D. CEO & Director 1955
Mr. Michael Lovell Sr. Director of Investor Relations NA
Ms. Katelyn Watson Chief Marketing Officer NA
Dr. Varun Choudhary DFAPA, M.A., M.D. Chief Medical Officer NA
Ms. Michaela Yule Chief Strategy Officer NA
Ms. Erin Boyd Chief Growth Officer of Enterprise 1969
Mr. Richie Nguyen Sr. VP of Network & Provider Operations NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…